Gene · 8644
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic reprogramming-related gene classifier distinguishes malignant from the benign pulmonary nodules. | Heliyon | 2024 | 39296187 | PubTator, text mining | PubMed |
| Adipocyte maturation impacts daunorubicin disposition and metabolism. | Eur J Clin Invest | 2024 | 39254480 | PubTator, text mining | PubMed |
| Decoding 11-oxygenated androgen synthesis: insights from enzyme gene expression and LC-MS/MS quantification. | Eur J Endocrinol | 2024 | 39219353 | PubTator, text mining | PubMed |
| Silencing of KIAA1429, a N6-methyladenine methyltransferase, inhibits the progression of colon adenocarcinoma via blocking the hypoxia-inducible factor 1 signalling pathway. | J Biochem Mol Toxicol | 2024 | 39215765 | PubTator, text mining | PubMed |
| Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN). | Kidney Int | 2024 | 39197587 | PubTator, text mining | PubMed |
| Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status. | J Exp Clin Cancer Res | 2024 | 39164746 | PubTator, text mining | PubMed |
| AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications. | ACS Med Chem Lett | 2024 | 39140045 | PubTator, text mining | PubMed |
| LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy. | Cancer Res | 2024 | 39088701 | PubTator, text mining | PubMed |
| The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia. | Front Immunol | 2024 | 39026664 | PubTator, text mining | PubMed |
| Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy. | Apoptosis | 2024 | 39023830 | PubTator, text mining | PubMed |
| Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections. | Cancers (Basel) | 2024 | 39001492 | PubTator, text mining | PubMed |
| A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification". | J Clin Med | 2024 | 38999437 | PubTator, text mining | PubMed |
| Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors. | ChemMedChem | 2024 | 38976686 | PubTator, text mining | PubMed |
| AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer. | Transl Oncol | 2024 | 38954974 | PubTator, text mining | PubMed |
| Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis. | J Autoimmun | 2024 | 38851089 | PubTator, text mining | PubMed |
| Absence of IL-6 Receptor Blockade Effect on the Outcomes of Transplant Glomerulopathy in the Absence of Anti-HLA Donor-specific Antibodies. | Transplant Direct | 2024 | 38769985 | PubTator, text mining | PubMed |
| Identifying the miRNA-gene networks contributes to exploring paravertebral muscle degeneration's underlying pathogenesis and therapy strategy. | Heliyon | 2024 | 38765163 | PubTator, text mining | PubMed |
| An integrated machine learning framework for developing and validating a diagnostic model of major depressive disorder based on interstitial cystitis-related genes. | J Affect Disord | 2024 | 38754597 | PubTator, text mining | PubMed |
| Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics. | Curr Pharm Des | 2024 | 38747231 | PubTator, text mining | PubMed |
| Evaluating the Diagnostic Performance of Large Language Models on Complex Multimodal Medical Cases. | J Med Internet Res | 2024 | 38739441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8644/papers?page=10